Key result
Intra-arterial tirofiban infusion resolved thromboemboli in 24 of 25 procedures during endovascular treatment of intracranial aneurysms, with no hemorrhagic complications.
Why the study?
Does intra-arterial tirofiban infusion resolve thromboembolism safely during endovascular treatment of intracranial aneurysms?
Observational (n=24)
Does intra-arterial tirofiban infusion resolve thromboembolism safely during endovascular treatment of intracranial aneurysms?
Intra-arterial tirofiban infusion appears to be a safe and highly effective rescue treatment for thromboembolism complicating endovascular treatment of intracranial aneurysms.
Answers are grounded in this paper and cite their sources.
May support tirofiban rescue in aneurysm embolization; hypothesis-generating and should not yet change practice.
OBJECTIVE: Thromboembolism is one of the most common and serious complications associated with the endovascular embolization of intracranial aneurysms. We report our clinical experiences with intra-arterial tirofiban infusion during aneurysm embolization. METHODS: The clinical, radiological, and laboratory data of 24 patients harboring 25 aneurysms (25 procedures) who underwent intra-arterial tirofiban infusion for thromboembolism during the endovascular treatment of intracranial aneurysms were reviewed retrospectively. Thrombi or emboli were resolved by superselective intra-arterial tirofiban infusion via a microcatheter. RESULTS: The study cohort comprised 14 unruptured and 11 ruptured aneurysms. Intra-arterially infused tirofiban doses ranged from 0.2 to 1.0 mg (mean +/- standard deviation, 0.64 +/- 0.25 mg). Thromboemboli were resolved, and arteries were recanalized on all occasions except one: a case of distal middle cerebral artery embolism. No hemorrhagic complications related to intra-arterial tirofiban infusion occurred. CONCLUSION: Intra-arterial tirofiban delivery appears to be a safe and effective treatment modality when thromboembolism is encountered during the endovascular treatment of intracranial aneurysms.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2008) conducted an observational in Thromboembolism during endovascular treatment of intracranial aneurysms (n=24). Intra-arterial tirofiban infusion was evaluated on Resolution of thromboemboli and arterial recanalization. Intra-arterial tirofiban infusion resolved thromboemboli in 24 of 25 procedures during endovascular treatment of intracranial aneurysms, with no hemorrhagic complications.
Synapse has enriched 10 related papers. Consider them for comparative context: